Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_assertion description "[The indications for SCT will be extended to include elderly patients undergoing allogeneic mini-transplants, and tumor eradication will be improved by better conditioning regimens such as radioimmunoconjugates and methods to induce the graft-versus-leukemia (GvL) effect, such as donor leukocyte infusions (DLI) or allogeneic mini-transplants applied after autologous transplants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_assertion evidence source_evidence_literature NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_assertion SIO_000772 11049022 NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_assertion wasDerivedFrom befree-20140225 NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_assertion wasGeneratedBy ECO_0000203 NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP303807.RAzkSpoeN6f5mYHHPE1ZRoQGcNndeSw8P3Zhbetp6VBwY130_provenance.